Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy.

Tan EH. et al, (2021), J health psychol

Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France, Germany, Spain, South Korea and the United States: an international network cohort study.

Duarte-Salles T. et al, (2020), Medrxiv

Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: A randomised controlled trial to evaluate the effect of short message service (SMS) reminder.

Tan EH. et al, (2020), Breast, 53, 77 - 84

Comparison of laboratory threshold criteria in drug-induced liver injury detection algorithms for use in pharmacovigilance.

Tan EH. et al, (2020), Pharmacoepidemiology and drug safety

Outcome-Based Critical Result Thresholds in the Adult Patient Population.

Tan EH. et al, (2019), Am j clin pathol, 152, 177 - 184

Relative criticalness of common laboratory tests for critical value reporting.

Yang Z. et al, (2019), J clin pathol, 72, 325 - 328

Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: study protocol of a randomised controlled trial to evaluate the effect of short message service (SMS) reminder.

He Y. et al, (2018), Bmc cancer, 18

Systematic review and meta-analysis of algorithms used to identify drug-induced liver injury (DILI) in health record databases.

Tan EH. et al, (2018), Liver int, 38, 742 - 753

Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study.

Velentzis LS. et al, (2016), Plos one, 11

How well does the MESTT correlate with CTCAE scale for the grading of dermatological toxicities associated with oral tyrosine kinase inhibitors?

Chan A. and Tan EH., (2011), Support care cancer, 19, 1667 - 1674

Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitors.

Tan EH. and Chan A., (2009), Ann pharmacother, 43, 1658 - 1666

Include forthcoming?